Glucose Responsiveness of β-Cells Depends on Fatty Acids.


Journal

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 16 4 2019
medline: 29 7 2021
entrez: 16 4 2019
Statut: ppublish

Résumé

Glucose-stimulated insulin secretion (GSIS) is the gold standard for β-cell function. Both experimental and clinical diabetology, i. e., preceding transplantation of isolated human islets, depend on functional testing. However, multiple factors influence GSIS rendering the comparison of different

Identifiants

pubmed: 30986881
doi: 10.1055/a-0884-2919
doi:

Substances chimiques

Aniline Compounds 0
Fatty Acids, Nonesterified 0
Insulin 0
Palmitates 0
Phenylpropionates 0
TUG-469 0
Glucose IY9XDZ35W2
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

644-653

Subventions

Organisme : 01GI0925
ID : German Center for Diabetes Research
Organisme : 01GI0925
ID : IZKF-Promotionskolleg of the Faculty of Medicine, University of Tuebingen
Organisme : 31-2008-416
ID : Human islets were provided through the JDRF

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Felicia Gerst (F)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany.
Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tuebingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.).

Christine Singer (C)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany.

Katja Noack (K)

Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Tuebingen, Tuebingen, Germany.

Dunia Graf (D)

Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Tuebingen, Tuebingen, Germany.

Gabriele Kaiser (G)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany.
Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tuebingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.).

Madhura Panse (M)

Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tuebingen, Tübingen, Germany.

Marketa Kovarova (M)

Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tuebingen, Tübingen, Germany.

Erwin Schleicher (E)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany.
Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tuebingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.).

Hans-Ulrich Häring (HU)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany.
Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tuebingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.).

Gisela Drews (G)

Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Tuebingen, Tuebingen, Germany.

Susanne Ullrich (S)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany.
Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tuebingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH